On the one hand, it has a detrimental effect on the survival of patients with pancreatic adenocarcinoma 55, and overexpression of cPLA2G4A and CHMP2B simultaneously is correlated to the higher grade of myxofibrosarcoma and myxoid liposarcoma 56. Here, CHMP2B is linked to pancreatic adenocarcinoma.